Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.3.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JC.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used